Delaware And Groningen

NEWARK, Delaware and GRONINGEN, Netherlands, July 26, 2010 - QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the completion of its acquisition of Xendo Drug Development BV (XDD), headquartered in Groningen, The Netherlands.